Article Versions Notes

Aiello A, Ruggieri S, Navarra A, Tortorella C, Vanini V, Haggiag S, Prosperini L, Cuzzi G, Salmi A, Quartuccio ME, et al. Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination. Vaccines. 2024; 12(8):926. https://doi.org/10.3390/vaccines12080926

Aiello, Alessandra, Serena Ruggieri, Assunta Navarra, Carla Tortorella, Valentina Vanini, Shalom Haggiag, Luca Prosperini, Gilda Cuzzi, Andrea Salmi, Maria Esmeralda Quartuccio, and et al. 2024. "Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination" Vaccines 12, no. 8: 926. https://doi.org/10.3390/vaccines12080926

Aiello, A., Ruggieri, S., Navarra, A., Tortorella, C., Vanini, V., Haggiag, S., Prosperini, L., Cuzzi, G., Salmi, A., Quartuccio, M. E., Altera, A. M. G., Meschi, S., Matusali, G., Vita, S., Galgani, S., Maggi, F., Nicastri, E., Gasperini, C., & Goletti, D. (2024). Anti-RBD Antibody Levels and IFN-γ-Specific T Cell Response Are Associated with a More Rapid Swab Reversion in Patients with Multiple Sclerosis after the Booster Dose of COVID-19 Vaccination. Vaccines, 12(8), 926. https://doi.org/10.3390/vaccines12080926